Context: Health is one of the commonly mentioned motivations behind food choices, and functional foods offer promising health benefits. Aims: In this study, the folklore claim of Cinnamomum tamala leaves as hepatoprotective functional food is evaluated. Settings and Design: Prophylactic and curative hepatoprotective properties of selected functional food was carried out against commonly used analgesic antipyretic paracetamol (PCM). Subjects and Methods: Prophylactic and curative hepatoprotective property of suspension of C. tamala leaves (SCT) was studied against PCM-induced hepatic damage in albino rats. Pre-and post-treatment with SCT, before and after PCM treatment, reduced the biochemical markers of hepatic damage like serum glutamic pyruvic transaminase, serum glutamic oxaloacetic transaminase, serum alkaline phosphatase, serum cholesterol, total and direct bilirubin, and tissue glutathione (GSH). Histopathological studies also revealed that pre-and post-treatment with SCT, before and after PCM treatment protected the liver from PCM-induced liver damage. In addition, an antioxidant study was carried out by in vitro lipid peroxidation. Statistical Analysis Used: Statistical analysis was performed with one-way analysis of variance (one-way) followed by Tukey test. Results: In this study, it has been found that prophylactic study showed better hepatoprotection than the curative study. Conclusions: In the prophylactic study, lipid peroxidation and protection of GSH may be the reason behind better hepatoprotection and C. tamala possess hepatoprotective activity possibly because of its antioxidant potential.
INTRODUCTION
The liver is an organ that has fascinated mankind; Galen considered liver as "principal instrument" of the body. [1] Since the liver is involved in the biochemical conversion of various endogenous and exogenously administered substances, there is a possibility of generation of free radicals. However, the liver has an integral system like the glutathione (GSH), etc., to scavenge them off. In spite of this the free radicals generated by some hepatotoxins, like paracetamol (PCM), may overpower the protective mechanism of the liver and cause hepatic damage. [2] Liver disorders are still a worldwide health problem. [3] The liver is continuously and variedly exposed environmental toxins and abused by poor drug habits and alcohol and prescribed and over-the-counter drug which can eventually lead to various liver ailment like hepatitis cirrhosis and alcoholic liver disease. [4] Treatment options for common liver diseases such as cirrhosis, fatty liver, and chronic hepatitis are problematic. The effectiveness of treatment such as interferon colchicine, penicillamine, and corticosteroid are inconsistent at best, and incidence of side effect is profound through the treatment is worse than the disease. [5] Recent studies point out that oxidative stress might be a crucial originating factor in the pathogenesis of liver diseases along with deficiency of GSH. [6] Due to enormous side effects of allopathic medicine, today the world is returning toward the natural options for diseases treatment. Nutraceuticals may provide micronutrients and nonnutritive phytochemicals that have established potential beneficial effects.
Plant material and suspension preparation
Indian systems of medicine consider that complex diseases can be treated with a complex combination of botanicals, unlike in the West, with single drugs. Whole foods are, hence, used in India as functional foods rather than supplements. [13] The leaves of C. tamala were purchased from the local market of Akola, India. The leaves are identified by the Department of Botany, Shri Shivaji Science College, Akola, India, where a voucher is deposited in the Herbarium. The dried leaves were pulverized in a grinder and passed through mesh no. 80. The sieved powder of the leaves was suspended in 2% gum acacia aqueous solution, which is referred as suspension of C. tamala (SCT), prior to administration.
Animals
Albino Wister rats (150-250 g) and mice (25-35 g ) were housed under standard conditions of constant temperature and lighting (12 h light/dark cycle). They had free access to standard pellet diet (Gold Mohur Lipton Indian Ltd.,) and water ad libitum. The Institutional Animal Ethical Committee of A. U., College of Pharmaceutical Sciences, Andhra University, Visakhapatnam approved by CPCSEA with registration number 515/01/a/CPCSEA approved the study.
Antioxidant activity
As the PCM-induced hepatotoxicity is due to lipid peroxidation and lowering of GSH. In vitro lipid peroxidation and in vivo GSH estimation are carried out to evaluate antioxidant activity of SCT.
In vitro lipid peroxidation
Inhibition of lipid peroxidation was determined by the method developed by Ohkawa et al. [14] Rat liver tissue weighing 10 g was homogenized with a Polytron homogenizer in ice-cold Tris-HCl buffer to produce a 25% w/v homogenate. Then it was centrifuged at 4000 rpm for 10 min. An aliquot of supernatant 0.1 ml was mixed with 0.1 ml of SCT at different concentrations, followed by addition of 0.1 ml of potassium chloride (30 mM), 0.1 ml of ascorbic acid (0.06 mM) as standard, and 0.1 ml of ammonium ferrous sulfate (0.16 mM) and were incubated for 1 h at 37°C. The reaction mixture was treated with 0.2 ml of sodium dodecyl sulfate (8.1%), 1.5 ml of thiobarbituric acid (0.8%), and 1.5 ml of 20% acetic acid (pH 3.5). The total volume was then made up to 4 ml by adding distilled water and kept in an oil bath at 100°C for 1 h. After the mixture had been cooled, 1 ml of distilled water and 5 ml of 15:1 v/v butanol-pyridine mixture were added. Following vigorous shaking, the tubes were centrifuged at 4000 rpm for 10 min, and the absorbance of the organic layer containing the thiobarbituric acid reactive substance was measured at 532 nm. A control was prepared using 0.1 ml of the respective vehicle in the place of SCT/ascorbic acid. The experiment was performed in triplicate. The percentage inhibition of lipid peroxidation was as follows. 
Tissue glutathione measurement
GSH measurements were performed using a modification of the Ellman procedure. [15] After hepatotoxicity study tissue samples were homogenized in ice-cold trichloroacetic acid (TCA) (1 g tissue plus 10 ml 10% TCA) in an ultraturrax tissue homogenizer. Briefly, after centrifugation at 3000 rpm for 10 min, 0.5 ml supernatant was added to 2 ml of 0.3 M disodium hydrogen phosphate solution. A 0.2 ml solution of dithiobis nitrobenzoate (0.4 mg/ml in 1% sodium citrate) was added, and the absorbance at 412 nm was measured immediately after mixing.
Acute toxicity study
The acute toxicity was performed in a group of 3 mice who were administered 2000 mg/kg body weight of SCT orally through an oral feeding tube. The animals were observed for 24 h for any sign of toxicity and lethality. [16] Hepatoprotective activity Preventive study Albino Wister rats of either sex were selected and divided into five groups each containing six rats. PCM, powder of the C. tamala and silymarin were dissolved in 2% gum acacia suspension. The treatment protocol was planned to study the effect of SCT in the preventive aspect of PCM-induced hepatotoxicity. [17] The treatment protocol is summarized and given below:
• Group 1: Normal control, 2% w/v gum acacia suspension orally, 1 ml/kg once daily for 3 days • Group 2: PCM as toxicant 2 g/kg orally once daily for 3 days • Group 3: SCT 200 mg/kg orally, 30 min prior to PCM 2 g/kg orally for 3 days • Group 4: SCT 400 mg/kg orally, 30 min prior to PCM 2 g/kg orally for 3 days • Group 5: Silymarin 100 mg/kg orally, 30 min prior to PCM 2 g/kg orally for 3 days.
On the 0 th day (1 day before the start of dosing) and on the 4 th day (next day of the last dosing) blood was collected by a retro-orbital puncture from all the animals. Serum was separated by centrifugation (3000 rpm for 15 min) and subjected to estimation of biochemical parameters such as SGPT, SGOT, ALP, serum cholesterol, and bilirubin. Then on the 4 th day, the animals were sacrificed, and a small piece of fresh liver is used for GSH estimation from all the above groups.
Curative study
The treatment protocol was planned to study the curative effect of SCT in PCM-induced hepatotoxicity. [17] The treatment protocol is summarized and given below:
• Group 1: Normal control, 2% w/v gum acacia suspension orally, 1 ml/kg once daily for 10 days • Group 2: PCM as toxicant 2 g/kg orally once daily for 3 days followed by 1 ml/kg 2% gum acacia suspension from 4 th day to 10 th day • Group 3: PCM 2 g/kg orally for 3 days followed by SCT 200 mg/kg orally from 4 th day to 10 th day • Group 4: PCM 2 g/kg orally for 3 days followed by SCT 400 mg/kg orally from 4 th day to 10 th day • Group 5: PCM 2 g/kg orally for 3 days followed by silymarin 100 mg/kg orally from 4 th day to 10 th day.
On the 0 th day (1 day before the start of dosing) and on the 11 th day (next day of the last dosing) blood was collected by retro-orbital puncture from all the animals. Serum was separated by centrifugation (3000 rpm for 15 min) and subjected to estimation of biochemical parameters such as SGPT, SGOT, ALP, cholesterol, and bilirubin.
Statistical analysis
Results were expressed as a mean ± standard error of the mean, (n = 6). Statistical analysis was performed with one-way analysis of variance (one-way) followed by Tukey test carried out by using Graphpad prism. P < 0.05 was considered to be statistically significant. *P < 0.05, **P < 0.01, and ***P < 0.001 when compared with toxicant group. [18] Fifty percentage of inhibition concentration (IC 50 ) for in vitro lipid peroxidation activity has been calculated by Microsoft Excel.
RESULTS
SCT and ascorbic acid at different concentrations (12.5-400 µg) inhibited the lipid peroxidation in a dose-dependent manner. The amount needed for 50% inhibition of lipid peroxidation by SCT and ascorbic acid was found to be 375.18 µg and 179.66 µg, respectively [ Table 1 ]. Three days treatment of 2 g/kg PCM drastically decreased tissue GSH levels (P < 0.001) compared to the normal control group. The lower and higher doses of SCT lowered the elevated levels of tissue GSH by PCM treatment in a dose-dependent manner. 200 mg/kg dose of SCT increased the level of GSH to 18.4% (P < 0.05) and 400 mg/kg dose of SCT increased it to 26.68 (P < 0.01) when compared to PCM-treated group (toxicant group). The standard drug silymarin at a dose of 100 mg/kg elevate the tissue GSH levels to 79.75% (P < 0.001) when compared with a PCM-treated group [ Table 2 ]. Oral administration of the SCT in acute toxicity studies at a dose of 2000 mg/kg body weight did not show any toxic signs and mortality during the observation period of 24 h in all the treated mice. The SCT was safe at 2000 mg/kg body weight and 1/10 th (200 mg/kg) and 1/5 th (400 mg/kg) of this cutoff dose have been selected for further in vivo studies. In PCM-induced hepatotoxicity, the dose of 2 g/kg body weight of PCM induced a significant increase in serum GPT, GOT, ALP, cholesterol, total bilirubin, and direct bilirubin levels when compared to the normal control group (P < 0.001). Pretreatment of rats with SCT significantly prevented the elevation of serum GPT, GOT, ALP, cholesterol, total bilirubin, and direct bilirubin levels as compared to PCM-treated group (Group 2). However, the lower dose of SCT caused a nonsignificant decrease in serum ALP and direct bilirubin in the prophylactic study [ Table 3 ]. Posttreatment of rats with SCT after PCM treatment in the curative study also prevented the elevation of serum GPT, GOT, ALP, cholesterol, total bilirubin, and direct bilirubin levels as compared to PCM-treated group (Group 2). However, the lower dose of SCT caused a nonsignificant decrease in serum GPT, ALP, cholesterol, and direct bilirubin. Even the higher dose of SCT caused a nonsignificant decrease in serum cholesterol and direct bilirubin in the curative study [ Table 4 ]. Silymarin as standard drug diminished the levels of all marker enzymes except serum direct bilirubin in both prophylactic and curative study significantly (P < 0.001) compared to the PCM-treated group. The percentage change in serum enzyme levels from 0 th day to 4 th day in the prophylactic study [ Figure 1 ] and on the 11 th day in the curative study [ Figure 2 ] was also calculated. This percentage of protection was inferior in the curative study compared to prophylactic study. The prophylactic study with SCT showed better results than the curative study.
DISCUSSION
PCM is an extensively used analgesic and antipyretic drug and, though safe when used at therapeutic doses, is associated with significant hepatotoxicity when taken in overdose. Under normal conditions, PCM is primarily metabolized in the liver by glucuronidation and sulfation. A small proportion of the drug is metabolized by several of the cytochrome P450 enzymes into the reactive intermediate N-acetyl-p-benzoquinoneimine (NAPQI), which is normally detoxified by GSH both nonenzymatically and enzymatically. In overdose, sulfation and glucuronidation become flooded and GSH is depleted by NAPQI. Excess of NAPQI causes oxidative stress and binds covalently to liver proteins. [19] [20] [21] In living systems, the liver is considered to be highly sensitive to toxic agents. The study of different enzyme activities such as SGOT, SGPT, serum ALP, total bilirubin, and cholesterol have been found to be of great value in the measurement of clinical and experimental liver damage. [22, 23] The extent of the PCM-induced hepatotoxic effect is assessed by the level of released cytoplasmic enzymes -SGPT, SGOT, ALP, cholesterol, total bilirubin, and direct bilirubin in circulation. An elevated level of SGOT is known to indicate liver damage due to viral hepatitis, cardiac infarction, and muscle injury. SGPT, a better bio-indicator of liver injury than SGOT, catalyses the conversion of alanine to pyruvate and glutamate, and is released in a similar manner. Serum ALP and bilirubin levels conversely are related to the function of the hepatic cell. The elevated level of serum ALP is due to increased synthesis, in the presence of increasing biliary pressure. [24] If any drug lowered these elevated levels of enzymes due to hepatotoxic agents, it may be the result of stabilization of plasma membrane thereby preserving the structural integrity of the cell, as well as the repair of hepatic tissue damage caused by PCM. [25] In this study, both prophylactic and curative study showed that due to 3 days treatment with PCM-induced a sharp rise in all above-mentioned liver enzymes when compared to the normal control group (P < 0.001). This is an indicator of cellular leakage and loss of functional integrity of cell membrane in the liver. [26] This study showed that orally pre-and post-treatment of rats with SCT suppressed PCM-induced liver damage by lowering the elevated enzymes levels remarkably mainly by the higher dose of SCT, an indication of stabilization of plasma membrane, as well as repair of hepatic tissue damage. Effective control of bilirubin level and ALP activity points toward an early progress in the secretary mechanism of the hepatic cell. It has been indicated that microviscosity of a membrane increases noticeably with an increase in cholesterol level in plasma. PCM-induced toxicity in rats may have altered membrane structure and function as suggested by the increases in cholesterol. This result is an indication of membrane rigidity caused by PCM. Alteration of biomembrane lipid profile disturbs its fluidity, permeability, the activity of associated enzymes, and transportation system. [27] In this study, it has been observed that cholesterol levels have been increased due to PCM treatment. However, treatment of rats with SCT inhibited the alteration of lipid membranes and fluidity; hence, lowered cholesterol level in plasma. The percentage change on the 4 th day and 11 th day in prophylactic and curative studies, respectively, also showed better hepatoprotection in prophylactic study [ Figures 1 and 2] . The higher dose showed better hepatoprotection compared to a lower dose of SCT.
Increased lipid peroxidation in hepatic tissues after administration of PCM could be expected owing to the depletion of GSH. [28] In our study, the in vitro lipid peroxidation of SCT showed percentage reduction comparable with standard ascorbic acid [ Table 1 ]. The IC 50 value for the SCT and standard ascorbic acid was found to be 375.18 µg and 179.66 µg, respectively. GSH is one of the most abundant tripeptide, nonenzymatic biological antioxidant present in the liver. Its functions are related with the removal of free radical species such as hydrogen peroxide, superoxide radicals, alkoxy radicals, and maintenance of membrane protein thiols and as a substrate for GSH peroxidase. [29] In our study, the lowered level of GSH due to PCM treatment (P < 0.001) was increased by SCT treatment in a dose-dependent manner [ Table 2 ]. PCM toxicity is due to the formation of toxic metabolites when a part of it is metabolized by cytochrome P 450 . Induction of cytochrome P 450 or depletion of hepatic GSH is a requirement for PCM-induced hepatotoxicity. [30] Therefore, the antihepatotoxic activity of the SCT may be due to inhibition of cytochrome P 450 , promotion of glucuronidation, reduction in lipid peroxidation, stimulation of hepatic regeneration, or activation of the functions of the reticuloendothelial systems.
Today we realized that diets rich in bioactive phytochemicals reduce the risk of degenerative disorders. Foods containing these phytochemicals, and commonly known as functional th day in prophylactic study Group 1 is normal control, Group 2 is toxicant group, Group 3 is suspension of Cinnamomum tamala 200 mg/kg treatment, Group 4 is suspension of Cinnamomum tamala 400 mg/kg treatment, and Group 5 is silymarin 100 mg/kg treatment in prophylactic study th day in curative study Group 1 is normal control, Group 2 is toxicant group, Group 3 is suspension of Cinnamomum tamala 200 mg/kg treatment, Group 4 is suspension of Cinnamomum tamala 400 mg/kg treatment, and Group 5 is silymarin 100 mg/kg treatment in curative study food, not only supply our diet with certain antioxidant vitamins like Vitamin C, Vitamin E, and pro-Vitamin A but also a complex mixture of other natural substances with antioxidant capacity. [28] Flavonoids like quercetin and polyphenols are reported from leaves [11] which are said to be good antioxidants. It has been reported that the leaves of C. tamala possess good antioxidant activity. [31, 32] These previous findings support the antioxidant role of SCT in hepatoprotection. In the conventional cooking system, we generally overcook our foods and damaged their essential nutrients and also important antioxidants. It has also been proved that heat treatment affect the antioxidant activity of vegetables and in many cases has been observed lower antioxidant capacity in processed samples versus raw vegetables. Nutrient antioxidants may act together to reduce reactive oxygen species level more effectively than single dietary antioxidants because they can function as synergists. [33] [34] [35] Consuming raw vegetables, fruits, and nuts are more beneficial than cooking them harshly. Hence, this study conducted on SCT leaves without any extraction procedure.
CONCLUSION
The SCT possess antioxidant and hepatoprotective activity. In this study, it has been found that prophylactic study showed better hepatoprotection than curative activity which may further support the antioxidant mechanism behind hepatoprotection. In prophylactic study, may be lipid peroxidation and protection of GSH are the reason behind better hepatoprotection but in the curative study already the lipid peroxidation and depletion of GSH will be produced before the commencement of SCT administration.
Although further studies are needed to rule out the possibilities of other mechanism of action.
